CHU Nantes
Nantes, France
38 recruiting
Showing 1–20 of 125 trials
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Venous Thromboembolism
Manuel Monreal120,000 enrolled257 locationsNCT02832245
Recruiting
Not Applicable
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
Solid TumorLeukemia
Gustave Roussy, Cancer Campus, Grand Paris1,800 enrolled29 locationsNCT05691608
Recruiting
Phase 2
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
InfectionsAcute Respiratory Distress Syndrome
BioAegis Therapeutics Inc.600 enrolled70 locationsNCT05947955
Recruiting
Not Applicable
Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia
Intubated Patient Requiring a Gastric Tube
Centre Hospitalier le Mans2,400 enrolledNCT05915663
Recruiting
Not Applicable
Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
Out of Hospital Cardiac Arrest (OHCA)Cardiac Arrest
Centre Hospitalier le Mans1,380 enrolled27 locationsNCT05486884
Recruiting
Not Applicable
Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia
Ventilator-Associated Pneumonia (VAP)
Nantes University Hospital686 enrolled41 locationsNCT06743529
Recruiting
Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Janssen Research & Development, LLC1,590 enrolled270 locationsNCT05552222
Recruiting
Phase 1
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC180 enrolled29 locationsNCT05652335
Recruiting
Phase 3
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Janssen Research & Development, LLC1,000 enrolled238 locationsNCT06662786
Recruiting
Not Applicable
Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke
Acute Stroke
University Hospital, Angers3,084 enrolled12 locationsNCT07065929
Recruiting
Phase 2
A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab
Cryoglobulinemic Vasculitis (CV)
Assistance Publique - Hôpitaux de Paris30 enrolledNCT07268521
Recruiting
Phase 1Phase 2
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Janssen Research & Development, LLC287 enrolled56 locationsNCT06385080
Recruiting
Phase 2
Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis
Bronchiectasis
Centre Hospitalier Intercommunal Creteil196 enrolled18 locationsNCT06368804
Recruiting
Sudden Cardiac Arrest Related to Sport in Young and Value of the Genetic Assessment: a French Prospective Register
Sudden Cardiac DeathSudden Cardiac Arrest
Rennes University Hospital80 enrolled26 locationsNCT06642168
Recruiting
Phase 3
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype
Hospital-Acquired Pneumonia
Nantes University Hospital450 enrolled26 locationsNCT06269900
Recruiting
Phase 3
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
EPPXLP
Tanabe Pharma America, Inc.301 enrolled51 locationsNCT05005975
Recruiting
Phase 1
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjogren's SyndromeSjogren DiseaseSjögren
Cullinan Therapeutics Inc.36 enrolled11 locationsNCT07041099
Recruiting
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
Diabetes MellitusDiabetesType 1 Diabetes
Insulet Corporation152 enrolled24 locationsNCT07317102
Recruiting
Phase 1Phase 2
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Colorectal, CancerNon-small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.534 enrolled53 locationsNCT06128551
Recruiting
Not Applicable
Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients
Giant Cell Arteritis (GCA)Doppler Ultrasound
Centre Hospitalier le Mans64 enrolled6 locationsNCT07060274